Back to NVAX
OPPENHEIMER & CO INC NVAX Position History
Novavax, Inc. • Healthcare
Quarters held
5
Latest value
$626K
Q3 2026
Peak value
$893K
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $641K |
| Q4 2025 | $241K |
| Q1 2026 | $856K |
| Q2 2026 | $893K |
| Q3 2026 | $626K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $626K | 57.9K | — | — |
| Q2 2026 | $893K | 94.8K | — | — |
| Q1 2026 | $856K | 105.2K | — | — |
| Q4 2025 | $241K | 35.8K | — | — |
| Q3 2025 | $641K | 73.9K | — | — |
Other funds holding NVAX
$133.4M
$131.6M
$121.2M
$120.8M
$110.6M
$110.6M
$102.4M